Given the multifactorial cause of Ménière\'s disease, five subtypes of Ménière\'s disease have recently been proposed. A knowledge of these subtypes will aid in the development of an appropriate treatment algorithm. Although newer treatments have not been developed, stepwise treatment algorithms have been proposed and can improve patient care. New MRI modalities and serum testing hold promise as clinical clues and biomarkers.
As these updated diagnostic criteria are used, Ménière\'s disease can be identified and treated more precisely. This will in turn allow for future randomized controlled studies to improve the quality of treatment options available. Future imaging, vestibular testing, and the potential for serum biomarkers may illuminate additional diagnostic criteria, only furthering the improvement in clinical care.
鉴于梅尼埃病的多因素原因,最近提出了梅尼埃病的五种亚型。了解这些亚型将有助于开发适当的治疗算法。尽管尚未开发出更新的治疗方法,逐步治疗算法已经提出,可以改善病人的护理。新的MRI模式和血清检测有望作为临床线索和生物标志物。
在使用这些更新的诊断标准时,梅尼埃的疾病可以被更精确地识别和治疗。这反过来将允许未来的随机对照研究,以提高可用治疗方案的质量。未来成像,前庭测试,血清生物标志物的潜力可以阐明其他诊断标准,只有进一步提高临床护理水平。